StockNews.AI
NPCE
StockNews.AI
181 days

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

1. NeuroPace, Inc. to report Q4 and full-year 2024 results on March 4. 2. Management will host a conference call at 1:30 PM PT for investors. 3. NeuroPace focuses on brain-responsive technology for epilepsy treatment.

Earnings
+5.8%Current Return
VS
-0.39%S&P 500
$13.4502/19 04:09 PM EDTEvent Start
$14.2302/20 10:31 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

The earnings report could reveal positive growth trends, often stimulating investor interest. Past earnings reports have frequently impacted stock prices positively.

How important is it?

The earnings report is crucial for assessing NeuroPace's financial health and market position. This can directly influence NPCE's valuation and investor sentiment.

Why Short Term?

Immediate price reaction expected surrounding the earnings announcement. Previous earnings calls have led to swift stock price fluctuations.

Related Companies

NPCE
February 19, 2025 16:05 ET  | Source: NeuroPace, Inc. MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://viavid.webcasts.com/starthere.jsp?ei=1706647&tp_key=43fdbb668b. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived on the company’s investor relations website at https://investors.neuropace.com/news-and-events/events and will be available for replay for at least 90 days after the event. About NeuroPace, Inc. Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. Investor Contact:Jeremy Feffer Managing Director LifeSci Advisorsjfeffer@lifesciadvisors.com

Related News